Replies to post #7729 on MannKind Corp. (MNKD)

[TREND1]

The 71 plus comments are just like this board.
A lot of pro and con.

[Profit]

If their is a sore spot in the marketing of Affezza not being approved by medicare or Medicaid would be it.